Immunology of cord blood T-cells favors augmented disease response during clinical pediatric stem cell transplantation for acute leukemia
Allogeneic hematopoietic stem cell transplantation (HSCT) has been an important and efficacious treatment for acute leukemia in children for over 60 years. It works primarily through the graft-vs.-leukemia (GVL) effect, in which donor T-cells and other immune cells act to eliminate residual leukemia...
Saved in:
Main Authors: | Roisin Borrill (Author), Kay Poulton (Author), Robert Wynn (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2023-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hematopoietic Stem Cell Transplantation in Inborn Errors of Metabolism
by: Emily Y. Tan, et al.
Published: (2019) -
Scientific production of nursing on transplantation of stem cells hematopoietic of cord blood
by: Magda Maria Barbosa da Silva, et al.
Published: (2018) -
Hematopoietic stem cell transplantation in children with acute leukemia: similar outcomes in recipients of umbilical cord blood versus marrow or peripheral blood stem cells from related or unrelated donors
by: Eun Sang Yi, et al.
Published: (2012) -
Clinical utilization of cord blood over human health: experience of stem cell transplantation and cell therapy using cord blood in Korea
by: Young-Ho Lee
Published: (2014) -
Immunological Considerations in In Utero Hematopoetic Stem Cell Transplantation (IUHCT)
by: Andrea Ivonne Loewendorf, et al.
Published: (2015)